Literature DB >> 19300202

Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults.

Fidéline Collin1, Xavier Duval, Vincent Le Moing, Lionel Piroth, Firas Al Kaied, Patrice Massip, Virginie Villes, Geneviève Chêne, François Raffi.   

Abstract

In the ANRS CO8 APROCO-COPILOTE cohort of patients treated with combination antiretroviral therapy since 1997-1999, the incidence density of bone fractures was 3.3 for 1000 patient-years [95% confidence interval (CI) = 2.0-4.6]. The rate was 2.9-fold (95% CI = 1.3-6.5) higher among patients with excessive alcohol consumption and 3.6-fold (95% CI = 1.6-8.1) higher in those with hepatitis C virus (HCV) coinfection. Specific monitoring of HCV/HIV-coinfected patients and active promotion of alcohol cessation should be recommended for the prevention of bone fractures.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19300202      PMCID： PMC2855855          DOI： 10.1097/QAD.0b013e3283292195

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


  10 in total

Review 1.  Bone disease and HIV infection.

Authors:  Valerianna Amorosa; Pablo Tebas
Journal:  Clin Infect Dis       Date:  2005-11-30       Impact factor: 9.079

Review 2.  Therapeutic management of bone demineralization in the HIV-infected population.

Authors:  Eugènia Negredo; Eva Martínez; Denise Cinquegrana; Carla Estany; Bonaventura Clotet
Journal:  AIDS       Date:  2007-03-30       Impact factor: 4.177

3.  Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy.

Authors:  P Tebas; W G Powderly; S Claxton; D Marin; W Tantisiriwat; S L Teitelbaum; K E Yarasheski
Journal:  AIDS       Date:  2000-03-10       Impact factor: 4.177

4.  Epidemiology of fractures in England and Wales.

Authors:  T P van Staa; E M Dennison; H G Leufkens; C Cooper
Journal:  Bone       Date:  2001-12       Impact factor: 4.398

5.  Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection.

Authors:  Julia H Arnsten; Ruth Freeman; Andrea A Howard; Michelle Floris-Moore; Yungtai Lo; Robert S Klein
Journal:  AIDS       Date:  2007-03-12       Impact factor: 4.177

Review 6.  HIV infection--a risk factor for osteoporosis.

Authors:  Joegi Thomas; Sheelagh M Doherty
Journal:  J Acquir Immune Defic Syndr       Date:  2003-07-01       Impact factor: 3.731

7.  Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy.

Authors:  Dario Bruera; Norma Luna; Daniel O David; Liliana M Bergoglio; Javier Zamudio
Journal:  AIDS       Date:  2003-09-05       Impact factor: 4.177

Review 8.  Bone disorders in chronic liver disease.

Authors:  Jane Collier
Journal:  Hepatology       Date:  2007-10       Impact factor: 17.425

9.  Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.

Authors:  Charles Cazanave; Michel Dupon; Valérie Lavignolle-Aurillac; Nicole Barthe; Sylvie Lawson-Ayayi; Nadia Mehsen; Patrick Mercié; Phillipe Morlat; Rodolphe Thiébaut; François Dabis
Journal:  AIDS       Date:  2008-01-30       Impact factor: 4.177

10.  Incidence of and risk factors for adverse drug reactions in a prospective cohort of HIV-infected adults initiating protease inhibitor-containing therapy.

Authors:  Xavier Duval; Valérie Journot; Catherine Leport; Geneviève Chêne; Michel Dupon; Lise Cuzin; Thierry May; Philippe Morlat; Anne Waldner; Roger Salamon; François Raffi
Journal:  Clin Infect Dis       Date:  2004-07-01       Impact factor: 9.079
  10 in total
  50 in total

Review 1.  Incident fractures in HIV-infected individuals: a systematic review and meta-analysis.

Authors:  Stephanie Shiau; Emily C Broun; Stephen M Arpadi; Michael T Yin
Journal:  AIDS       Date:  2013-07-31       Impact factor: 4.177

Review 2.  Impact of metabolic complications on antiretroviral treatment adherence: clinical and public health implications.

Authors:  Jean B Nachega; Maria Paola Trotta; Mark Nelson; Adriana Ammassari
Journal:  Curr HIV/AIDS Rep       Date:  2009-08       Impact factor: 5.071

3.  Prevalence of abnormal bone mineral density in hiv-positive patients in ibadan, Nigeria.

Authors:  T O Alonge; V N Okoje-Adesomoju; O M Atalabi; H A Obamuyide; D Olaleye; I F Adewole
Journal:  J West Afr Coll Surg       Date:  2013 Oct-Dec

Review 4.  HIV and Bone Complications: Understudied Populations and New Management Strategies.

Authors:  Michael T Yin; Todd T Brown
Journal:  Curr HIV/AIDS Rep       Date:  2016-12       Impact factor: 5.071

Review 5.  HIV and bone metabolism.

Authors:  Ighovwerha Ofotokun; M Neale Weitzmann
Journal:  Discov Med       Date:  2011-05       Impact factor: 2.970

Review 6.  Hepatitis C.

Authors:  Daniel P Webster; Paul Klenerman; Geoffrey M Dusheiko
Journal:  Lancet       Date:  2015-02-14       Impact factor: 79.321

7.  Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTG A5202.

Authors:  Grace A McComsey; Douglas Kitch; Eric S Daar; Camlin Tierney; Nasreen C Jahed; Pablo Tebas; Laurie Myers; Kathleen Melbourne; Belinda Ha; Paul E Sax
Journal:  J Infect Dis       Date:  2011-06-15       Impact factor: 5.226

Review 8.  Ageing and inflammation in patients with HIV infection.

Authors:  M Nasi; S De Biasi; L Gibellini; E Bianchini; S Pecorini; V Bacca; G Guaraldi; C Mussini; M Pinti; A Cossarizza
Journal:  Clin Exp Immunol       Date:  2016-08-09       Impact factor: 4.330

9.  Increased risk of fragility fractures among HIV infected compared to uninfected male veterans.

Authors:  Julie A Womack; Joseph L Goulet; Cynthia Gibert; Cynthia Brandt; Chung Chou Chang; Barbara Gulanski; Liana Fraenkel; Kristin Mattocks; David Rimland; Maria C Rodriguez-Barradas; Janet Tate; Michael T Yin; Amy C Justice
Journal:  PLoS One       Date:  2011-02-16       Impact factor: 3.240

10.  Increased Fracture Incidence in Middle-Aged HIV-Infected and HIV-Uninfected Women: Updated Results From the Women's Interagency HIV Study.

Authors:  Anjali Sharma; Qiuhu Shi; Donald R Hoover; Kathryn Anastos; Phyllis C Tien; Mary A Young; Mardge H Cohen; Elizabeth T Golub; Deborah Gustafson; Michael T Yin
Journal:  J Acquir Immune Defic Syndr       Date:  2015-09-01       Impact factor: 3.731
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.